Table 2.
Observed incidence SSI, % [95% CI] | Expected incidence SSI, % [95% CI] | RAER [95% CI] | p Value | |
---|---|---|---|---|
Skin antiseptic agent | ||||
CHG | 4.0 [3.1–5.0] | 4.7 [4.2–5.1] | 0.85 [0.78–1.10] | 0.28 |
CHG+IPA | 4.5 [4.0–5.2] | 4.1 [3.8–4.5] | 1.10 [1.00–1.21] | 0.06 |
PVI | 6.0 [4.3–8.0] | 6.1 [5.2–7.0] | 0.98 [0.85–1.15] | 0.96 |
IPC+IPA | 5.3 [3.3–7.9] | 5.7 [4.7–6.7] | 0.93 [0.79–1.12] | 0.51 |
Sub group IPA vs non-IPA | ||||
Non-IPA | 4.5 [3.7–5.4] | 5.0 [4.6–5.4] | 0.91 [0.76–1.09] | 0.39 |
IPA | 4.6 [4.0–5.2] | 4.2 [3.9–4.6] | 1.10 [1.00–1.19] | 0.07 |
CHG, chlorhexidine; CHG+IPA, chlorhexidine in isopropyl alcohol; PVI, povidone-iodine; IPC+IPA, povacrylex-iodine in isopropyl alcohol; IPA, isopropyl alcohol; RAER, risk adjusted event rates; SSI, surgical site infection.